Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Pilot Study of Topotecan/Vincristine With Subconjunctival Carboplatin for Patients With Bilateral Retinoblastoma
- Status
- WITHDRAWN
- Phase
- NA
Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE2
Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
AXIS 2: AX200 for the Treatment of Ischemic Stroke
- Status
- COMPLETED
- Phase
- PHASE2
Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial
- Status
- COMPLETED
- Phase
- PHASE2
Granulocyte-colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease
- Status
- TERMINATED
- Phase
- PHASE2
Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine The Effect of a Drug Called Neupogen on Stroke Recovery
- Status
- UNKNOWN
- Phase
- PHASE1
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1